ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.11
0.01 (0.11%)
At close: Aug 18, 2025, 3:59 PM
5.91
-3.27%
After-hours: Aug 18, 2025, 04:47 PM EDT

ImmuCell Revenue

ImmuCell reported an annual revenue of $26.49M, reflecting a 51.64% growth. For the quarter ending March 31, 2025, ImmuCell generated $8.07B in revenue.
Revenue (ttm)
26.49M
Revenue Growth
51.64%
Price / Sales Ratio
1.59
Revenue / Employee
383.96K
Employees
69
Market Cap
55.22M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 26.49M +51.64%
Dec 31, 2023 17.47M -5.90%
Dec 31, 2022 18.57M -3.51%
Dec 31, 2021 19.24M +25.43%
Dec 31, 2020 15.34M +11.80%
Dec 31, 2019 13.72M +24.91%
Dec 31, 2018 10.99M +5.32%
Dec 31, 2017 10.43M +9.29%
Dec 31, 2016 9.54M -6.69%
Dec 31, 2015 10.23M +34.64%
Dec 31, 2014 7.6M +26.46%
Dec 31, 2013 6.01M +11.45%
Dec 31, 2012 5.39M +5.45%
Dec 31, 2011 5.11M +16.53%
Dec 31, 2010 4.39M -2.72%
Dec 31, 2009 4.51M -2.70%
Dec 31, 2008 4.63M -23.65%
Dec 31, 2007 6.07M +26.41%
Dec 31, 2006 4.8M -3.65%
Dec 31, 2005 4.98M +34.82%
Dec 31, 2004 3.7M +10.10%
Dec 31, 2003 3.36M -45.72%
Dec 31, 2002 6.18M -7.37%
Dec 31, 2001 6.68M +18.47%
Dec 31, 2000 5.64M +14.80%
Dec 31, 1999 4.91M +9.09%
Dec 31, 1998 4.5M -2.17%
Dec 31, 1997 4.6M +4.55%
Dec 31, 1996 4.4M -10.20%
Dec 31, 1995 4.9M +11.36%
Dec 31, 1994 4.4M +12.82%
Dec 31, 1993 3.9M +25.81%
Dec 31, 1992 3.1M +40.91%
Dec 31, 1991 2.2M -26.67%
Dec 31, 1990 3M +7.14%
Dec 31, 1989 2.8M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.